Royalty Pharma has established a strong portfolio of royalty agreements and has successfully funded numerous biopharmaceutical projects, demonstrating significant growth in its revenue streams.
Company Description
Royalty Pharma is a leading buyer of biopharmaceutical royalties and a provider of capital to the biopharmaceutical industry. The company focuses on acquiring royalties from approved drugs and providing funding to support the development of new therapies.